Advisors Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.97M | Sell |
41,171
-4,900
| -11% | -$211K | 0.03% | 607 |
|
|
2026
Q1 | $1.69M | Buy |
46,071
+11,816
| +34% | +$560K | 0.03% | 653 |
|
|
2025
Q4 | $1.74M | Sell |
34,255
-8,880
| -21% | -$454K | 0.03% | 638 |
|
|
2025
Q3 | $2.39M | Sell |
43,135
-13,960
| -24% | -$817K | 0.04% | 536 |
|
|
2025
Q2 | $3.94M | Sell |
57,095
-20,804
| -27% | -$1.42M | 0.07% | 378 |
|
|
2025
Q1 | $5.41M | Sell |
77,899
-1,340
| -2% | -$111K | 0.1% | 255 |
|
|
2024
Q4 | $6.82M | Sell |
79,239
-17,497
| -18% | -$1.89M | 0.13% | 184 |
|
|
2024
Q3 | $11.5M | Buy |
96,736
+13,668
| +16% | +$1.82M | 0.21% | 105 |
|
|
2024
Q2 | $11.9M | Buy |
83,068
+14,968
| +22% | +$1.98M | 0.23% | 81 |
|
|
2024
Q1 | $8.74M | Buy |
68,100
+17,035
| +33% | +$2.03M | 0.17% | 141 |
|
|
2023
Q4 | $5.28M | Buy |
51,065
+5,440
| +12% | +$538K | 0.11% | 231 |
|
|
2023
Q3 | $4.15M | Buy |
45,625
+8,061
| +21% | +$710K | 0.09% | 284 |
|
|
2023
Q2 | $3.04M | Buy |
37,564
+6,854
| +22% | +$560K | 0.06% | 379 |
|
|
2023
Q1 | $2.44M | Buy |
30,710
+824
| +3% | +$58.4K | 0.05% | 459 |
|
|
2022
Q4 | $2.02M | Buy |
29,886
+10,694
| +56% | +$627K | 0.04% | 495 |
|
|
2022
Q3 | $956K | Buy |
19,192
+540
| +3% | +$28.9K | 0.02% | 743 |
|
|
2022
Q2 | $1.04M | Buy |
18,652
+5,632
| +43% | +$313K | 0.02% | 746 |
|
|
2022
Q1 | $723K | Sell |
13,020
-2,616
| -17% | -$134K | 0.01% | 896 |
|
|
2021
Q4 | $876K | Sell |
15,636
-1,160
| -7% | -$62.8K | 0.01% | 856 |
|
|
2021
Q3 | $806K | Buy |
16,796
+1,120
| +7% | +$54.1K | 0.01% | 887 |
|
|
2021
Q2 | $657K | Buy |
15,676
+2,310
| +17% | +$89.5K | 0.01% | 942 |
|
|
2021
Q1 | $451K | Buy |
13,366
+3,082
| +30% | +$110K | 0.01% | 1038 |
|
|
2020
Q4 | $359K | Sell |
10,284
-1,800
| -15% | -$62.2K | 0.01% | 1069 |
|
|
2020
Q3 | $419K | Buy |
12,084
+646
| +6% | +$21.5K | 0.01% | 967 |
|
|
2020
Q2 | $374K | Sell |
11,438
-2,042
| -15% | -$65.2K | 0.01% | 993 |
|
|
2020
Q1 | $406K | Sell |
13,480
-11,604
| -46% | -$346K | 0.01% | 901 |
|
|
2019
Q4 | $726K | Sell |
25,084
-3,358
| -12% | -$93K | 0.01% | 859 |
|
|
2019
Q3 | $735K | Sell |
28,442
-12,990
| -31% | -$328K | 0.01% | 858 |
|
|
2019
Q2 | $1.06M | Buy |
41,432
+1,806
| +5% | +$44.6K | 0.02% | 760 |
|
|
2019
Q1 | $1.04M | Buy |
39,626
+2,804
| +8% | +$68.9K | 0.02% | 775 |
|
|
2018
Q4 | $848K | Buy |
36,822
+3,538
| +11% | +$78.6K | 0.02% | 818 |
|
|
2018
Q3 | $785K | Sell |
33,284
-1,148
| -3% | -$28K | 0.01% | 924 |
|
|
2018
Q2 | $794K | Buy |
34,432
+14,470
| +72% | +$344K | 0.01% | 917 |
|
|
2018
Q1 | $514K | Buy |
19,962
+398
| +2% | +$10.4K | 0.01% | 1048 |
|
|
2017
Q4 | $525K | Buy |
19,564
+5,202
| +36% | +$132K | 0.01% | 1065 |
|
|
2017
Q3 | $346K | Sell |
14,362
-7,688
| -35% | -$174K | 0.01% | 1150 |
|
|
2017
Q2 | $473K | Sell |
22,050
-3,666
| -14% | -$74K | 0.01% | 1115 |
|
|
2017
Q1 | $441K | Sell |
25,716
-53,722
| -68% | -$935K | 0.01% | 1144 |
|
|
2016
Q4 | $1.42M | Sell |
79,438
-10,686
| -12% | -$194K | 0.02% | 758 |
|
|
2016
Q3 | $1.87M | Sell |
90,124
-45,812
| -34% | -$1.14M | 0.03% | 640 |
|
|
2016
Q2 | $3.65M | Sell |
135,936
-14,064
| -9% | -$386K | 0.06% | 456 |
|
|
2016
Q1 | $4.06M | Sell |
150,000
-42,226
| -22% | -$1.13M | 0.07% | 418 |
|
|
2015
Q4 | $5.58M | Sell |
192,226
-6,696
| -3% | -$185K | 0.09% | 324 |
|
|
2015
Q3 | $5.39M | Buy |
198,922
+5,168
| +3% | +$146K | 0.09% | 322 |
|
|
2015
Q2 | $5.3M | Buy |
193,754
+21,132
| +12% | +$594K | 0.07% | 369 |
|
|
2015
Q1 | $4.61M | Buy |
172,622
+22,862
| +15% | +$526K | 0.06% | 402 |
|
|
2014
Q4 | $3.17M | Buy |
149,760
+14,662
| +11% | +$328K | 0.04% | 488 |
|
|
2014
Q3 | $3.22M | Buy |
135,098
+10,966
| +9% | +$252K | 0.04% | 454 |
|
|
2014
Q2 | $2.87M | Buy |
124,132
+15,646
| +14% | +$345K | 0.04% | 482 |
|
|
2014
Q1 | $2.48M | Buy |
108,486
+22,346
| +26% | +$476K | 0.04% | 498 |
|
|
2013
Q4 | $1.59M | Buy |
86,140
+11,610
| +16% | +$202K | 0.03% | 584 |
|
|
2013
Q3 | $1.26M | Buy |
74,530
+4,750
| +7% | +$79.9K | 0.02% | 610 |
|
|
2013
Q2 | $1.08M | Buy |
+69,780
| New | +$1.16M | 0.02% | 617 |
|
Other funds holding NVO
F
Advisors Asset Management's NVO Position: Q2 2026 in Review
Advisors Asset Management reduced its Novo Nordisk (NVO) stake by 11% in Q2 2026, selling an estimated $211K and leaving 41,171 shares worth $1.97M. The position accounts for 0.03% of the portfolio, ranked #607.
Advisors Asset Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.9M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Advisors Asset Management held 41,171 shares of Novo Nordisk worth $1.97M as of Q2 2026.
- Advisors Asset Management sold 4,900 Novo Nordisk shares in Q2 2026, an estimated $211K.
- Novo Nordisk made up 0.03% of Advisors Asset Management's portfolio in Q2 2026, its #607 holding.
- Advisors Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- Advisors Asset Management's Novo Nordisk position peaked at $11.9M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.